A new study could change the way we understand and treat dementia and other degenerative disorders of the brain ...

FDA-approved protocol update significantly expands patient eligibility criteria for the BACKBEAT global pivotal study (“BACKBEAT study”), resulting in an estimated more than 24-fold increase in the ...